Shen, S., Xu, Y., Zhou, Y., Mao, F., Guan, J., & Sun, Q. (2017). Concurrent administration of trastuzumab and anthracyclines as adjuvant regimen for HER2-positive breast cancer: A randomised controlled trial. Oncotarget.
Stile di citazione ChicagoShen, Songjie, Ying Xu, Yidong Zhou, Feng Mao, Jinghong Guan, e Qiang Sun. "Concurrent Administration of Trastuzumab and Anthracyclines As Adjuvant Regimen for HER2-positive Breast Cancer: A Randomised Controlled Trial." Oncotarget 2017.
Citazione MLAShen, Songjie, et al. "Concurrent Administration of Trastuzumab and Anthracyclines As Adjuvant Regimen for HER2-positive Breast Cancer: A Randomised Controlled Trial." Oncotarget 2017.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.